UK markets open in 3 hours 1 minute
NIKKEI 225
39,044.75 +427.65 (+1.11%) HANG SENG
18,919.81 -275.79 (-1.44%) CRUDE OIL
77.15 -0.42 (-0.54%) GOLD FUTURES
2,373.00 -19.90 (-0.83%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,545.32 -399.54 (-0.73%)
Santen Pharmaceutical Co., Ltd. (SZD.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:03AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 3.31B |
| Enterprise value | 2.76B |
| Trailing P/E | 21.24 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.87 |
| Price/book (mrq) | 1.82 |
| Enterprise value/revenue | 1.55 |
| Enterprise value/EBITDA | 9.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.26 |
| 52-week change 3 | 8.38% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 9.75 |
| 52-week low 3 | 7.35 |
| 50-day moving average 3 | 8.97 |
| 200-day moving average 3 | 8.75 |
Share statistics
| Avg vol (3-month) 3 | 37 |
| Avg vol (10-day) 3 | 64 |
| Shares outstanding 5 | 363.21M |
| Implied shares outstanding 6 | 366.26M |
| Float 8 | 348.89M |
| % held by insiders 1 | 2.79% |
| % held by institutions 1 | 50.86% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.2 |
| Forward annual dividend yield 4 | 2.26% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 2.16 |
| Payout ratio 4 | 45.60% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 27 Sept 2024 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 27 Mar 2015 |
Financial highlights
Currency in JPY.Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 8.82% |
| Operating margin (ttm) | 3.01% |
Management effectiveness
| Return on assets (ttm) | 5.62% |
| Return on equity (ttm) | 8.92% |
Income statement
| Revenue (ttm) | 301.96B |
| Revenue per share (ttm) | 823.04 |
| Quarterly revenue growth (yoy) | -0.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 56.72B |
| Net income avi to common (ttm) | 26.64B |
| Diluted EPS (ttm) | 0.43 |
| Quarterly earnings growth (yoy) | -97.40% |
Balance sheet
| Total cash (mrq) | 94.96B |
| Total cash per share (mrq) | 261.62 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 2.55 |
| Book value per share (mrq) | 843.19 |
Cash flow statement
| Operating cash flow (ttm) | 72.65B |
| Levered free cash flow (ttm) | 50.53B |
© 2024 Yahoo. All rights reserved.